PT  - JOURNAL ARTICLE
AU  - Jiawen Deng
TI  - Therapeutic use of blood products for the treatment of autoimmune hemolytic anemia: A network meta-analysis protocol
AID  - 10.1101/2020.01.15.20017657
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.01.15.20017657
4099  - http://medrxiv.org/content/early/2020/05/06/2020.01.15.20017657.short
4100  - http://medrxiv.org/content/early/2020/05/06/2020.01.15.20017657.full
AB  - Autoimmune hemolytic anemia is a rare blood disorder that can result in anemic hypoxia. Currently, red blood cell (RBC) transfusion is the only effective method of treating this condition. We propose a network meta-analysis that investigates whether the use of different types of blood products (e.g. suspended RBC, leukoreduced RBC, washed RBC, etc.) can decrease adverse events, increase the rate of remission and improve lab results, including hemoglobin, RBC, reticulocyte counts, hematocrit and total bilirubin.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialStudy under review at PROSPERO: 165509Funding StatementNo funding was received for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll available data are disclosed in the manuscript.